News in Brief

Hologram Sciences unveils first integrated supplement/home test product

By Hank Schultz contact

- Last updated on GMT

©Getty Images - ipopba
©Getty Images - ipopba

Related tags: Vitamin d deficiency, vitamin d fortification, Vitamin d intake, COVID-19

New DSM division Hologram Sciences has launched its first product, a direct to consumer brand based on vitamin D that includes a testing component.

The brand, called d.velop, is touted as a “holistic immunity solution.”​ The supplement is based on the calcifediol form of the ingredient.  Calcifediol is also known as 25-hydroxyvitamin D3, which is the form created in the liver from other sources of vitamin D.  Supplementing with this form directly is claimed by the company to be three times more effective at achieving optimum blood levels of vitamin D that are the other forms of the vitamin commonly sold as supplements.

In addition to the supplement itself, the new launch is being offered with a home testing kit and access to digital support.

Vitamin D has gotten a lot of attention recently for its demonstrated effects in helping individuals avoid COVID-19 infections in the first place and weather them better if they are infected.  Most of the support for this has come from large scale observational studies carried out in various regions since the start of the pandemic. Now that various jurisdictions are starting to reopen to normal commerce, the new product can help consumers participate again in open social life with full confidence, said Hologram CEO Ian Brady.

 “We chose to focus our first brand and product on immunity because we wanted to give people a tool to feel more confident about their health as they step back into the world,” ​Brady said.

New division based on earlier acquisition

Brady came on board at DSM when it acquired his previous start up, called AVA, which is a digital personalized nutrition platform. Brady founded AVA after his wife suffered her third bout of gestational diabetes with the birth of the couple’s third child. 

“She felt very isolated.  There weren’t a lot of answers out there, and I started to think long term about how to stop this from happening again.  I was surprised by the lack of technology,”​ he said.

DSM acquired AVA for an undisclosed amount in late 2019.  That acquisition followed a research partnership that DSM concluded in 2018 with testing company Wellmetrix to look into testing technologies and platforms as the large ingredient supplier moves steadily into personalized nutrition.

Related news

Related products

show more

Uncover emerging immunity trends and opportunities

Uncover emerging immunity trends and opportunities

DSM Nutritional Products | 20-Sep-2022 | Technical / White Paper

Today’s consumers see immunity as a top priority for year-round wellbeing and are taking greater ownership of their immune health. To help you stay ahead...

Whitepaper: Optimizing immunity with vitamin D

Whitepaper: Optimizing immunity with vitamin D

DSM Nutritional Products | 16-Jun-2022 | Technical / White Paper

With vitamin D science evolving rapidly since the COVID-19 pandemic, our new whitepaper breaks down the latest research on the role of vitamin D in supporting...

Botanicals you can rely on, from ADM

Botanicals you can rely on, from ADM

ADM | 02-Jun-2022 | Product Brochure

Today more than ever, consumers are striving to support their overall well-being in a convenient way, with foods, beverages and dietary supplements that...

Mediterranean Nutraceutical products

Mediterranean Nutraceutical products

Esserre Pharma | 19-Apr-2022 | Product Brochure

From the best Mediterranean ingredients to effective and safe finished products, Esserre Pharma researches and develops unique formulations.

Follow us

Products

View more

Webinars